QSV Equity Investors LLC Acquires 10,190 Shares of Astrana Health, Inc. $ASTH

Key Points

• QSV Equity Investors LLC increased its stake in Astrana Health, Inc. by 34.4%, acquiring an additional 10,190 shares, bringing its total ownership to 39,786 shares worth approximately $1,234,000.
• Astrana Health reported a 34.7% increase in revenue year-over-year, with a reported revenue of $654.81 million for the quarter, although it missed earnings per share expectations.
• The company's stock has seen fluctuations with a 52-week range between $21.20 and $63.20, reflecting a market cap of $1.64 billion.

QSV Equity Investors LLC raised its position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 34.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,786 shares of the company's stock after purchasing an additional 10,190 shares during the period. QSV Equity Investors LLC owned 0.07% of Astrana Health worth $1,234,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Wells Fargo & Company MN raised its stake in shares of Astrana Health by 41.5% in the 4th quarter. Wells Fargo & Company MN now owns 22,484 shares of the company's stock valued at $709,000 after acquiring an additional 6,596 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in shares of Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after acquiring an additional 1,184 shares in the last quarter. Invesco Ltd. raised its stake in shares of Astrana Health by 6.9% in the 4th quarter. Invesco Ltd. now owns 258,520 shares of the company's stock valued at $8,151,000 after acquiring an additional 16,717 shares in the last quarter. Barclays PLC raised its stake in shares of Astrana Health by 3.4% in the 4th quarter. Barclays PLC now owns 79,543 shares of the company's stock valued at $2,507,000 after acquiring an additional 2,627 shares in the last quarter. Finally, Marshall Wace LLP bought a new position in shares of Astrana Health in the 4th quarter valued at approximately $2,821,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Performance

Shares of ASTH stock traded up $0.71 during trading on Friday, reaching $30.68. The company had a trading volume of 347,033 shares, compared to its average volume of 340,094. The firm's 50 day simple moving average is $25.16 and its two-hundred day simple moving average is $28.72. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. Astrana Health, Inc. has a one year low of $21.20 and a one year high of $63.20. The company has a market capitalization of $1.72 billion, a PE ratio of 60.16, a PEG ratio of 0.72 and a beta of 0.85.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The company had revenue of $654.81 million during the quarter, compared to the consensus estimate of $639.13 million. During the same period in the previous year, the business posted $0.40 earnings per share. The firm's revenue was up 34.7% on a year-over-year basis. Astrana Health has set its Q3 2025 guidance at EPS. Sell-side analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.